Literature DB >> 2584299

High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue.

K Tyczkowska1, K M Hedeen, D P Aucoin, A L Aronson.   

Abstract

A simple and sensitive high-performance liquid chromatographic method was developed for the determination of enrofloxacin and ciprofloxacin in canine serum and prostatic tissue. Sample preparation consisted of mixing canine serum with a 1:1 dilution of acetonitrile and 0.1 M sodium hydroxide followed by ultrafiltration through a 10,000 molecular mass cut-off filter. Prostatic tissue was sonicated with the same solution prior to ultrafiltration. Separation of these two quinolones in the ultrafiltrate was accomplished by ion-paired liquid chromatography using a reversed-phase analytical column eluted with an acetonitrile-methanol-water solution. Enrofloxacin and ciprofloxacin were detected by a photometric ultraviolet-visible detector set at 278.6 nm and confirmed by a photodiode array detector operating from 230 to 360 nm. The limits of detection for enrofloxacin and ciprofloxacin were 4 and 2 ng/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584299     DOI: 10.1016/s0378-4347(00)82739-5

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

1.  Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus.

Authors:  I A Parshikov; J P Freeman; J O Lay; R D Beger; A J Williams; J B Sutherland
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats.

Authors:  Myung-Jin Choi; Sileshi Belew Yohannes; Seung-Jin Lee; Dereje Damte; Jong-Choon Kim; Joo-Won Suh; Seung-Chun Park
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-06-08       Impact factor: 2.441

3.  Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China.

Authors:  Xiuting He; Zhaohui Wang; Xiangping Nie; Yufen Yang; Debo Pan; Anna O W Leung; Zhang Cheng; Yongtao Yang; Kaibin Li; Kunci Chen
Journal:  Environ Geochem Health       Date:  2011-09-01       Impact factor: 4.609

4.  The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.

Authors:  L Intorre; G Mengozzi; S Bertini; M Bagliacca; E Luchetti; G Soldani
Journal:  Vet Res Commun       Date:  1997-02       Impact factor: 2.459

5.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment.

Authors:  Y H Hwang; M S Kim; I B Song; J H Lim; B K Park; H I Yun
Journal:  Vet Res Commun       Date:  2008-12-16       Impact factor: 2.459

7.  Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms.

Authors:  V Ashok Chakravarthy; B B V Sailaja; Avvaru Praveen Kumar
Journal:  J Anal Methods Chem       Date:  2015-01-29       Impact factor: 2.193

8.  Evaluation of physicochemical properties as supporting information on quality control of raw materials and veterinary pharmaceutical formulations.

Authors:  Sara da Silva Anacleto; Marcella Matos Cordeiro Borges; Hanna Leijoto de Oliveira; Andressa Reis Vicente; Eduardo Costa de Figueiredo; Marcone Augusto Leal de Oliveira; Bárbara Juliana Pinheiro Borges; Marcelo Antonio de Oliveira; Warley de Souza Borges; Keyller Bastos Borges
Journal:  J Pharm Anal       Date:  2018-01-17

9.  Treatment of pigs with enrofloxacin via different oral dosage forms - environmental contaminations and resistance development of Escherichia coli.

Authors:  Paula Janssen; Gesine Barton; Manfred Kietzmann; Jessica Meißner
Journal:  J Vet Sci       Date:  2022-01-10       Impact factor: 1.672

10.  E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Authors:  Mengjie Guo; Yong Sun; Yu Zhang; Shamsuddin Bughio; Xiaohua Dai; Weilong Ren; Liping Wang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.